Andreas Wallnoefer
Direktor/Vorstandsmitglied bei Eyebiotech Ltd.
Aktive Positionen von Andreas Wallnoefer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Direktor/Vorstandsmitglied | - | - |
Jeito Capital SASU
 Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Private Equity Investor | 01.10.2021 | - |
Karriereverlauf von Andreas Wallnoefer
Statistik
International
| Vereinigtes Königreich | 2 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 1 |
| Private Equity Investor | 1 |
Sektoral
| Health Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Finance |
- Börse
- Insiders
- Andreas Wallnoefer
- Erfahrung
